MYGN   $4.825  1.79% Market Open

Myriad Genetics, Inc.
Total Cash 97.30M
totalCashPerShare 1.071
EBITDA -49.00M
Total Debt 143.30M
quickRatio 1.445
currentRatio 1.958
Total Revenue 802.20M
debtToEquity 19.352
Revenue/Share 9.2
ROA -0.05683
ROE -0.21034001
grossProfits
freeCashflow -102.36M
operatingCashflow -92.80M
earningsGrowth
revenueGrowth 0.153
grossMargins 0.69073
ebitdaMargins -0.061079998
operatingMargins -0.11773
profitMargins -0.19347
enterpriseValue 1.65B
forwardPE 65.77778
floatShares 83.27M
sharesOutstanding 90.82M
sharesShort 4.49M
sharesShortPriorMonth 3.94M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.04%
Short Ratio help_outline 6.48%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 8.146
Price To Book help_outline 2.18
earningsQuarterlyGrowth
netIncomeToCommon -155.20M
trailingEps -1.77%
forwardEps 0.27%
enterpriseToEbitda -33.58
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.02 3Q 2024
institutionsCount 330
lastUpdated Nov. 6, 2024, 8:24 p.m.